Flexion Therapeutics, Inc.
FLXN
FLXN was delisted on the 18th of November, 2021.
65 hedge funds and large institutions have $125M invested in Flexion Therapeutics, Inc. in 2016 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 29 increasing their positions, 13 reducing their positions, and 15 closing their positions.
306% more call options, than puts
Call options by funds: $406K | Put options by funds: $100K
123% more repeat investments, than reductions
Existing positions increased: 29 | Existing positions reduced: 13
2% more funds holding
Funds holding: 64 → 65 (+1)
7% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 15
57% less capital invested
Capital invested by funds: $288M → $125M (-$164M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$15.9M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$5M |
| 3 |
Bank of New York Mellon
New York
|
+$4.87M |
| 4 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$1.94M |
| 5 |
Millennium Management
New York
|
+$1.52M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$56M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$8.88M |
| 3 |
BBA
Baker Bros. Advisors
New York
|
-$2.83M |
| 4 |
Invesco
Atlanta,
Georgia
|
-$2.75M |
| 5 |
WSA
Wall Street Associates
Lajolla,
California
|
-$2.74M |
FLXN Hedge Fund Activity: Q1 2016 in Review
65 of the 3,767 institutional investors tracked by Wall St. Rank reported a position in Flexion Therapeutics, Inc. (FLXN) for Q1 2016, worth a combined $125M — down 57% from $288M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new FLXN positions and 15 closed out — a net gain of 1 holder — while 29 added to existing stakes and 13 trimmed.
The largest buyer was Gilder Gagnon Howe & Co, adding an estimated $15.9M. The largest seller was Jennison Associates, exiting entirely with an estimated $56M sold.
- 65 institutional investors held Flexion Therapeutics, Inc. (FLXN) as of Q1 2016, up from 64 in Q4 2015.
- Funds reported $125M of Flexion Therapeutics, Inc. stock for Q1 2016, down 57% quarter-over-quarter.
- 16 funds opened new Flexion Therapeutics, Inc. positions in Q1 2016 and 15 closed out, a net change of +1 holder.
- The largest Flexion Therapeutics, Inc. buyer in Q1 2016 was Gilder Gagnon Howe & Co, an estimated $15.9M added.
- The largest Flexion Therapeutics, Inc. seller in Q1 2016 was Jennison Associates, an estimated $56M sold.
Based on aggregated 13F filings for Q1 2016.